Abstract
Too much abdominal (visceral) fat increases an individual's risk of developing insulin resistance and other metabolic disorders. In a Perspective, [Hug and Lodish][1] discuss the unexpected finding that blood levels of a hormone produced by visceral fat, called visfatin, correlate with obesity ([ Fukuhara et al .][2]). Surprisingly, visfatin has beneficial, insulin-like activity and is able to bind to the insulin receptor, lowering blood glucose levels. The implications of this finding for diabetes research and therapy are discussed by the Perspective authors. [1]: http://www.sciencemag.org/cgi/content/full/307/5708/366 [2]: http://www.sciencemag.org/cgi/content/short/307/5708/426
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
